TY - JOUR
T1 - Antigen presentation
T2 - Lysoyme, autoimmune diabetes, and listeria - What do they have in common?
AU - Unanue, Emil
AU - Byersdorfer, Craig
AU - Carrero, Javier
AU - Levisetti, Matteo
AU - Lovitch, Scott
AU - Pu, Zheng
AU - Suri, Anish
N1 - Funding Information:
We acknowledge the very competent and experienced technical staff of our laboratory and our trainees who participate in many aspects of the research program (Boris Calderon, Yoichi Maekawa, Jake Simmons, Alex Estrada, Kuan Chang, Danielle Atiba-lentja). Our colleagues in the immunology program provided much help. The National Institutes of Health and the National Institute for Allergy and Infectious Diseases provided grants that made our investigations possible. Part of the research in autoimmune diabetes was supported by the Kilo Diabetes and Vascular Research Foundation.
PY - 2005
Y1 - 2005
N2 - We discuss three areas of antigen presentation and macrophage biology being investigated in the laboratory. Using hen egg-white lysozyme as a protein antigen, all the segments of the molecules selected by the class II histocompatibility molecule I-Ak were identified and characterized. The display of each family of peptides was explained biochemically and quantitated. Conformational isomers of a peptide-major histocompatibility complex (MHC) complex were identified. The relationship between the amounts of peptide-MHC displayed by the antigen-presenting cells and two biologic responses, central thymic selection and T-cell responses after immunization in adjuvant, were examined. The class II MHC molecule of the nonobese diabetic I-Ag7 is being examined for its properties of peptide selection. The objective is to identify the diabetogenic peptides, as well as the repertoire of protein antigens from β-cells that trigger autoantibodies. The I-Ag7 molecule selects peptides that show very distinctive sequence motifs: one or more acidic residues at the carboxy terminus that interact at the P9 pocket of the binding groove. Finally, the investigations in listeriosis examined the early events in immune induction. More important, we found that Listeria causes marked apoptosis of lymphocytes around infective foci resulting from the apoptogenic properties of the pore-forming molecule Listeriolysin O.
AB - We discuss three areas of antigen presentation and macrophage biology being investigated in the laboratory. Using hen egg-white lysozyme as a protein antigen, all the segments of the molecules selected by the class II histocompatibility molecule I-Ak were identified and characterized. The display of each family of peptides was explained biochemically and quantitated. Conformational isomers of a peptide-major histocompatibility complex (MHC) complex were identified. The relationship between the amounts of peptide-MHC displayed by the antigen-presenting cells and two biologic responses, central thymic selection and T-cell responses after immunization in adjuvant, were examined. The class II MHC molecule of the nonobese diabetic I-Ag7 is being examined for its properties of peptide selection. The objective is to identify the diabetogenic peptides, as well as the repertoire of protein antigens from β-cells that trigger autoantibodies. The I-Ag7 molecule selects peptides that show very distinctive sequence motifs: one or more acidic residues at the carboxy terminus that interact at the P9 pocket of the binding groove. Finally, the investigations in listeriosis examined the early events in immune induction. More important, we found that Listeria causes marked apoptosis of lymphocytes around infective foci resulting from the apoptogenic properties of the pore-forming molecule Listeriolysin O.
KW - Antigen presentation
KW - Antigen processing
KW - Diabetes mellitus
KW - Histocompatibility molecules
KW - Listeria monocytogenes
KW - Lymphocyte apoptosis
KW - Nonobese diabetic mouse
UR - http://www.scopus.com/inward/record.url?scp=23844431564&partnerID=8YFLogxK
U2 - 10.1385/IR:32:1-3:267
DO - 10.1385/IR:32:1-3:267
M3 - Review article
C2 - 16106079
AN - SCOPUS:23844431564
SN - 0257-277X
VL - 32
SP - 267
EP - 292
JO - Immunologic Research
JF - Immunologic Research
IS - 1-3
ER -